GlaxoSmithKline Share Price (GSK)

0.00 0.00 (0.00%) delayed: 1:41AM BST
Bid price 1,590.40 Open price 0.00
Ask price 1,590.80 Prev close 1,590.40
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live GlaxoSmithKline share prices, GlaxoSmithKline stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get GlaxoSmithKline Level 2 Data, indepth research tools and investor commentary for GlaxoSmithKline (GSK) and other London Stock Exchange equities.

GlaxoSmithKline Share Price Chart

Advanced Charts >>

Register now for FREE GlaxoSmithKline share price charts

GlaxoSmithKline Share Price Information

Name GlaxoSmithKline Epic GSK
Sector Pharmaceuticals & Biotechnology ISIN GB0009252882
Activites GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market. GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders. GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Around 35,000 employees work at 82 manufacturing sites in 37 countries and over 15,000 are in R&D. GSK R&D is based at 24 sites in 11 countries. The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about £2.8bn/$5bn. Index FTSE 100

GlaxoSmithKline Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 87.01
Market Capitalisation (£m) 76,919.73 Gross Gearing (%) 93.81
Shares in issue (m) 4,960.00 Debt Ratio 88.30
P/E Ratio 49.39 Debt-to-Equity Ratio 0.50
Total dividends per share (p) 80.00 Assets / Equity Ratio 16.16
Dividend Yield (%) 5.16 Price to book value 22.05
Dividend cover (x) 0.39 ROCE (%) 11.82
Earning per share (p) 31.40 EPS Growth (%) 67.02
52 week high / low 1,612.80 / 1,236.40 DPS Growth (%) 0.00

GlaxoSmithKline Director Deals

Dec.Date Type Director Pos No. of Shares
31/07/2018 DRI Simon Dingemans FD 1,895
25/07/2018 BUY Sir Philip Hampton CH 2,810
25/07/2018 BUY Urs Rohner NED 462
25/07/2018 BUY Manvinder Banga NED 462
25/07/2018 BUY Dr Vivienne Cox NED 341

More GlaxoSmithKline Director Deals >>

GlaxoSmithKline Company News

16:51 15/08/2018

Global equities slump on falling copper prices and mounting concerns over Turkey

There was a sea of red on the global markets as a toxic combo of a strong dollar, falling copper price and concern over Turkey's crisis and slower Chinese growth hit investor sentiment. Copper cheapened 4.2% to $2.56 per pound and gold declined 1.2% to $1,178 per ounce. Brent crude oil slid 2.3%...

11:54 15/08/2018

Weakness in the mining sector hits FTSE

A slump in the mining sector on lower copper prices dragged the FTSE 100 down 0.8% to 7,548 around midday on a quiet day for corporate news. Copper cheapened 2.3% to $2.61 per pound and gold shed 0.6% to $1,185 per ounce. Fresnillo topped the blue-chip fallers, down 4.8% at 926.2p, followed by...

09:03 15/08/2018

UK stocks open flat as Turkey contagion fears linger

UK stocks had a directionless open on Wednesday as investors continued to fret about a potential global fallout from Turkey's currency crisis and lower metal prices hurt miners. At 0858, the benchmark FTSE 100 index had inched up 1.43 points to 7.613.07. Construction group Belfour Beatty rose...

More GlaxoSmithKline Company News >>

Register now for FREE GlaxoSmithKline company news

GlaxoSmithKline Share Price Discussions

more than 1 year ago

Glaxo trading near low (GSK)

there seems to be some heavy resistance around these level with a lot of potential upside.

more than 1 year ago

Traders Thread - Friday 13th February (GSK)

UK PreMarket Futures FTSE +8 DAX Unch DOW +26 S&P +2 Nasdaq +5 1 Day 2 Day...

more than 1 year ago

Traders Thread - Friday 13th February (GSK)

UK PreMarket Futures FTSE +8 DAX Unch DOW +26 S&P +2 Nasdaq +5 1 Day 2 Day...

Register now for FREE GlaxoSmithKline share price discussions